Paul O’Gorman Building, University College London,
72 Huntley Street, London, WC1E 6DD
United Kingdom

The Witney Group at UCL's Centre for Advanced Biomedical Imaging. Specialising in the development of advanced cancer imaging tools.

Tim Witney

Group leader

Dr Tim Witney

Wellcome Trust/Royal Society Sir Henry Dale Fellow,

UCL Excellence Fellow,

Head, Molecular Imaging @CABI

Email: t.witney@ucl.ac.uk

Office: +44 20 8383 5837

 

Tim Witney

research experience

2015 - Present

Sir Henry Dale Fellow, University College London.

University College London Excellence Fellow.

Head, Molecular Imaging at UCL's Centre for Advanced Biomedical Imaging.  

2013 - 2015

Postdoctoral Research Scholar, Gambhir Lab, Molecular Imaging Program at Stanford (MIPS), Stanford University, USA.

2010 - 2013

Postdoctoral Research Associate, Comprehensive Cancer Imaging Centre, Imperial College London, UK.

2006 - 2010

PhD CASE Studentship, Brindle Group, University of Cambridge, UK.

 

Current research grants

2015 - 2020

Wellcome Trust/Royal Society Sir Henry Dale Fellowship, "Detecting Tumour Resistance with Positron Emission Tomography".

2015 - 2018

UCL Excellence Fellowship, "Cancer Detection and Assessment of Treatment Resistance with Positron Emission Tomography".

2015 - 2016

Cancer Research UK - UCL Centre Development Fund, "Detecting Tumour Resistance with Positron Emission Tomography".

 

Honours and awards

The Society of Nuclear Medicine and Molecular Imaging’s Alavi-Mandell Publication Award 2015

In recognition of outstanding contributions to the field from young scientists who have published (as first authors) original articles in The Journal of Nuclear Medicine.

Young Investigator Award finalist, European Molecular Imaging Meeting 2015

"Imaging tumor glycolysis downstream of hexokinase through noninvasive measurement of pyruvate kinase M2".

Medicinal Chemistry Communications top journal article of the year, 2013

L. Carroll, T.H. Witney & E.O. Aboagye (2013). Design and synthesis of novel 18F-radiolabelled glucosamine derivatives for cancer imaging.  Med Chem Commun 4, pp.653-656. 

 

PubLications

Publication list available here.